Clinical Trial Update: Acetyl-L-Carnitine In Severe Hepatic Encephalopathy [NA]

View source ↗

Summary

Completed clinical trial evaluating acetyl-L-carnitine for severe hepatic encephalopathy (Grade 3 West Haven).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: University of Catania | Conditions: Hepatic Encephalopathy (Grade 3 of the West Haven Grading Scale) | NA | Status: COMPLETED